{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T12:11:43Z","timestamp":1760616703592,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.rmed.2019.04.018","type":"journal-article","created":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T12:10:53Z","timestamp":1556280653000},"page":"37-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Use of aclidinium did not increase the risk of death in a noninterventional cohort study in the Clinical Practice Research Datalink (CPRD), United Kingdom"],"prefix":"10.1016","volume":"152","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8064-5997","authenticated-orcid":false,"given":"Cristina","family":"Rebordosa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaume","family":"Aguado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Estel","family":"Plana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Frances","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejhandra","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Garc\u00eda-Gil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Nuevo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susana","family":"Perez-Gutthann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Castellsague","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2019.04.018_bib1","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2147\/COPD.S62750","article-title":"Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns","volume":"9","author":"Price","year":"2014","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"year":"2018","series-title":"Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2018 Report), Global Initiative for Chronic Obstructive Lung Disease","author":"GOLD","key":"10.1016\/j.rmed.2019.04.018_bib2"},{"issue":"10","key":"10.1016\/j.rmed.2019.04.018_bib3","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1164\/rccm.200906-0876OC","article-title":"UPLIFT study investigators. Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease","volume":"180","author":"Celli","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"16","key":"10.1016\/j.rmed.2019.04.018_bib4","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1056\/NEJMoa1303342","article-title":"Tiotropium Respimat inhaler and the risk of death in COPD","volume":"369","author":"Wise","year":"2013","journal-title":"N. Engl. J. Med."},{"author":"AstraZeneca","key":"10.1016\/j.rmed.2019.04.018_bib5"},{"author":"Novartis Europharm Limited","key":"10.1016\/j.rmed.2019.04.018_bib6"},{"author":"Glaxo Group Ltd","key":"10.1016\/j.rmed.2019.04.018_bib7"},{"author":"AstraZeneca","key":"10.1016\/j.rmed.2019.04.018_bib8"},{"issue":"Suppl 2","key":"10.1016\/j.rmed.2019.04.018_bib9","first-page":"122","article-title":"Are you really dead? Validation of death and date of death in patients with COPD in CPRD","volume":"27","author":"Rivero-Ferrer","year":"2018","journal-title":"Pharmacoepidemiol. Drug Saf."},{"year":"2008","series-title":"Modern Epidemiology","author":"Rothman","key":"10.1016\/j.rmed.2019.04.018_bib10"},{"year":"2016","series-title":"Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2016 Report), Global Initiative for Chronic Obstructive Lung Disease","author":"GOLD","key":"10.1016\/j.rmed.2019.04.018_bib11"},{"year":"2015","series-title":"Implementing GLI 2012 Lung Function Regression Equations [Global Lung Initiative ERS Task Force (TF-2009-03) Equations]","author":"Stock","key":"10.1016\/j.rmed.2019.04.018_bib12"},{"issue":"12","key":"10.1016\/j.rmed.2019.04.018_bib13","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.2337\/dc12-0788","article-title":"Metformin and the risk of cancer: time-related biases in observational studies","volume":"35","author":"Suissa","year":"2012","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.rmed.2019.04.018_bib14","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/aje\/kwm324","article-title":"Immortal time bias in pharmaco-epidemiology","volume":"167","author":"Suissa","year":"2008","journal-title":"Am. J. Epidemiol."},{"issue":"2","key":"10.1016\/j.rmed.2019.04.018_bib15","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/EDE.0b013e3182093a0f","article-title":"Time-window bias in case-control studies: statins and lung cancer","volume":"22","author":"Suissa","year":"2011","journal-title":"Epidemiology"},{"issue":"1","key":"10.1016\/j.rmed.2019.04.018_bib16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41533-017-0040-z","article-title":"Determinants of initial inhaled corticosteroid use in patients with GOLD A\/B COPD: a retrospective study of UK general practice","volume":"27","author":"Chalmers","year":"2017","journal-title":"NPJ Prim. Care Respir. Med."},{"issue":"4","key":"10.1016\/j.rmed.2019.04.018_bib17","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/sim.4780100409","article-title":"Channeling bias in the interpretation of drug effects","volume":"10","author":"Petri","year":"1991","journal-title":"Stat. Med."},{"issue":"2","key":"10.1016\/j.rmed.2019.04.018_bib18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1001\/jamainternmed.2017.7720","article-title":"Association of cardiovascular risk with inhaled long-acting bronchodilators in patients with chronic obstructive pulmonary disease: a nested case-control study","volume":"178","author":"Wang","year":"2018","journal-title":"JAMA Intern. Med."},{"issue":"1","key":"10.1016\/j.rmed.2019.04.018_bib19","first-page":"5","article-title":"Long-term evaluation of the effects of aclidinium bromide on major adverse cardiovascular events and COPD exacerbations in patients with moderate to very severe COPD: rationale and design of the ASCENT COPD study","volume":"5","author":"Wise","year":"2018","journal-title":"Chronic Obstr. Pulm. Dis."},{"year":"2018","series-title":"Conference Coverage. Aclidinium Bromide for COPD: No Impact on MACE. CHEST Physician","author":"Brunk","key":"10.1016\/j.rmed.2019.04.018_bib20"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611119301398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611119301398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:50:27Z","timestamp":1760615427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611119301398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":20,"alternative-id":["S0954611119301398"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2019.04.018","relation":{},"ISSN":["0954-6111"],"issn-type":[{"type":"print","value":"0954-6111"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of aclidinium did not increase the risk of death in a noninterventional cohort study in the Clinical Practice Research Datalink (CPRD), United Kingdom","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2019.04.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}